4D Molecular Therapeutics (FDMT) Payables (2019 - 2026)
4D Molecular Therapeutics (FDMT) reported Payables of $12.52 million for Q2 2026, up 43.9% from $8.7 million a year earlier but down 14.8% from the prior quarter.
4D Molecular Therapeutics (FDMT) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, 4D Molecular Therapeutics posted Payables of $11.16 million, up 154.4% from FY2024.
- Payables has increased for three consecutive years, with a five-year compound annual growth rate of 44.2% (FY2020 to FY2025).
- By year, Payables came in at $4.39 million in FY2024 (+24.8%), $3.52 million in FY2023 (+5.8%), $3.32 million in FY2022 (-30.3%) and $4.76 million in FY2021 (+166.6%).
- Five-year quarterly Payables spans a low of $1.48 million in Q3 2022 and a high of $14.69 million in Q1 2026.
- Year over year, Payables has now increased in each of the last five quarters, with growth averaging 90.7% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q1 2026 (growth of 253.9%); the low point was Q3 2022 (a decline of 60.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.69 million (Q1 2026), $11.16 million (Q4 2025) and $6.86 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.89 Bn | 1,138.48 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 648.35 Bn | 568.21 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 504.24 Bn | 477.35 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 303.28 Bn | 267.27 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 242.76 Bn | 198.16 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.99 Bn | 119.64 Bn | 10.94 Bn | 7.03 Bn |
| 10 | 4D Molecular Therapeutics | 856.26 Mn | -603.68 Mn | - | 12.52 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Mn |
| Mar 31, 2026 | 14.69 Mn |
| Dec 31, 2025 | 11.16 Mn |
| Sep 30, 2025 | 6.86 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 4.22 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 4.71 Mn |
| Jun 30, 2023 | 3.49 Mn |
| Mar 31, 2023 | 2.41 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 3.32 Mn |
| Mar 31, 2022 | 2.68 Mn |
| Dec 31, 2021 | 4.76 Mn |
| Sep 30, 2021 | 3.71 Mn |
4D Molecular Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=FDMT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();